Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to ...
Morning Overview on MSN
Study: RNA drugs work best when they reshape RNA, not just bind to it
Researchers led by Davide Incarnato at the University of Groningen have demonstrated that the FDA-approved cancer drug ...
Ribonucleic acids (RNAs) serve as messengers between DNA and protein production, and perform a wide variety of regulatory ...
The latest study from the Sharma Lab makes the mechanisms of how epigenetic information is established in sperm cells, and how that encoding affects offspring health, a little less of a scientific ...
Mental illnesses such as schizophrenia and bipolar disorder are complex and not fully understood. For a long time, ...
WALTHAM, Mass.--(BUSINESS WIRE)--Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, today announced that ...
Mammalian immunity has long been thought to rely solely on proteins and specialized immune cells. However, a newly proposed concept—RNA immunity—is reshaping this perspective. In a recent publication ...
This article and associated images are based on a poster originally authored by Rose Bigley, James Craswell, Michael Carter, Philip Fallon, and Nicholas Bland, and presented at ELRIG Drug Discovery ...
Not everything inside us is, strictly speaking, us. The closer we look at the genome, the more we appreciate the role of small RNAs in what we call epigenetic inheritance. That’s when traits get ...
Adding another name to an impressive roster of partners assembled over the past few years, Skyhawk Therapeutics Inc. inked a neurology-focused deal with Merck KGaA aimed at discovering small-molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results